Contrive Datum Insights has published "Keratin Tablets Market Size, Share & Industry Analysis, By Type (Alpha-keratin, Beta-keratin), Application (Pharmacy, Supermarket, Online Store), Formulation (Keratin-only Formula, Keratin + Biotin Complex, Keratin + Collagen Complex), End use (Hair Health, Skin Health, Nail Health, Hair-Skin-Nail Combined), Dosage form (Standard Tablets, Chewable Tablets, Effervescent Tablets), and Regional Forecast, 2026-2034". The study sizes the global keratin tablets market at USD 312.4 million in 2025 and projects growth from USD 337.5 million in 2026 to USD 576 million by 2034, a compound annual growth rate of 6.92% across the forecast period.
Keratin tablets are oral dietary supplements formulated with hydrolyzed keratin protein, typically combined with biotin, collagen or other micronutrients, marketed for hair strength, skin elasticity and nail health. They are sold as standard, chewable or effervescent tablets through pharmacy, mass retail and online channels to adult consumers seeking a beauty-from-within routine, not a medical treatment for hair or skin conditions.
Rising consumer adoption of beauty-from-within supplement routines
Rising consumer adoption of beauty-from-within supplement routines is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 6.92% a year, the type lines exposed to it move fastest: Beta-keratin compounds at 8.94%, taking its share of revenue from 32% to 38% and its value from USD 99.97 million to USD 218.88 million.
The study also runs a bull case: the bull case assumes faster-than-expected growth in online and subscription-based purchasing alongside broader retail distribution of combination keratin-biotin-collagen formulations. That path ends 2034 at USD 657 million, above the USD 576 million base case.
The downside is specific. The bear case assumes tighter regulatory scrutiny of hair, skin and nail health claims and slower consumer adoption as private-label alternatives compress branded pricing, and 2034 revenue lands at USD 497.5 million. Alpha-keratin is the drag, 68% of the 2025 base compounding at 5.82% while the market runs at 6.92%.
Key Players Compete on Alpha-keratin Volume and Beta-keratin Growth
Competition in the global keratin tablets market runs along the type axis, not the regional one. Alpha-keratin holds 68% of 2025 revenue at USD 212.43 million and remains the largest line through 2034 at 62%, making it the position hardest for a challenger to take. Beta-keratin, growing at 8.94%, is where share actually changes hands. A supplier established in one is not thereby established in the other, so a field of this size persists in a market of USD 312.4 million.
Other Findings in the Study
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Type | Alpha-keratin | 68% · USD 212.43 million | — |
| Application | Pharmacy | 38% · USD 118.71 million | Online Store 10.15% |
| Formulation | Keratin + Biotin Complex | 42% · USD 131.21 million | Keratin + Collagen Complex 9.21% |
| End use | Hair Health | 46% · USD 143.7 million | Hair-Skin-Nail Combined 9.08% |
| Dosage form | Standard Tablets | 58% · USD 181.19 million | Effervescent Tablets 10.33% |
- Regionally, the lead sits with North America: 42% of 2025 global revenue, USD 131.21 million rising to USD 218.88 million in 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 22% in 2025 to 27% in 2034, with revenue growing from USD 68.73 million to USD 155.52 million.
- At 5% of 2025 revenue and 5.5% by 2034, Middle East and Africa is the smallest region throughout.
- No type line grows faster than Beta-keratin, at a projected 8.94%.
- The United States is the largest single country market at USD 102.34 million in 2025, 32.76% of global revenue.
The report segments the market across five axes; by type, and by application, formulation, end use and dosage form; with revenue and a growth rate for every line in every year from 2020 to 2034, alongside bear, base and bull scenarios for the headline total at USD 497.5 million and USD 657 million by 2034. It covers all five regions with country-level breakdowns, the competitive landscape, and the research methodology behind every estimate. Delivered as a PDF; a free sample is available on request.